-+ 0.00%
-+ 0.00%
-+ 0.00%

Biodexa Pharmaceuticals Announces Pricing Of $5M Registered Direct Offering And Concurrent Private Placement

Benzinga·07/19/2024 12:32:08
Listen to the news

To Sell 5,050,808 American Depositary Shares And 278,975 Pre-Funded Warrants; Proceeds To Fund Development Programs Including $17M CPRIT Grant Match And Phase 3 eRapa Trial In Familial Adenomatous Polyposis, Working Capital, And General Corporate Purposes